MMSI vs XRAY
As of Sep 20, 2026, Merit Medical Systems (MMSI) scores 6.3/10 and DENTSPLY SIRONA (XRAY) 3.5/10 on AlphaStocks' five-model composite, so MMSI scores higher. MMSI trades 33% above its model fair value.
MMSI
MERIT MEDICAL SYSTEMS INC
6.3
Consider Buy
$85.33
XRAY
DENTSPLY SIRONA Inc.
3.5
Weak
$9.55
MMSI vs XRAY: Which is the Better Investment?
MERIT MEDICAL SYSTEMS INC (MMSI) scores 6.3/10 while DENTSPLY SIRONA Inc. (XRAY) scores 3.5/10 on AlphaStocks' composite model. MERIT MEDICAL SYSTEMS INC has the higher composite rating of Consider Buy.
This comparison is algorithmically generated and is not financial advice.
| Metric | MMSI | XRAY |
|---|---|---|
| Scores & Fundamentals | ||
| Composite Score | 6.3/10▲ | 3.5/10 |
| Rating | Consider Buy▲ | Weak |
| Price | $85.33 | $9.55 |
| P/E Ratio | 40.1 | — |
| ROE | 8.3%▲ | -42.5% |
| Market Cap | $5B | $2B |
| Fair Value | $64.30 | — |
| Dividend Yield | — | 5.2% |
| Sector Rank | #36 of 168▲ | #149 of 168 |
| Model Verdicts | ||
| Piotroski | Strong▲ | Attractive |
| Buffett | Attractive▲ | Neutral |
| Graham | Neutral▲ | Caution |
| Lynch | Neutral | Neutral |
| Greenblatt | Neutral | Strong▲ |
Related comparisons
MMSI vs XRAY: Which Stock Scores Higher?
MERIT MEDICAL SYSTEMS INC (MMSI) and DENTSPLY SIRONA Inc. (XRAY) are both in the Health Care sector. MMSI currently leads with a composite score of 6.3/10 (Consider Buy) compared to XRAY's 3.5/10 (Weak).
The AlphaStocks composite score evaluates each stock across four dimensions: Quality (business strength measured by Piotroski F-Score and Buffett quality criteria), Value (discount to intrinsic worth using Graham, Lynch, and Greenblatt models), Momentum (6-month price trend), and Timing (a confirmation signal that requires both value and momentum to align). A higher composite score indicates stronger overall fundamentals combined with favorable market conditions.
This comparison uses the same scoring framework for both companies, ensuring an apples-to-apples evaluation. Scores are recalculated daily after market close using data from SEC filings and market prices. Read the full methodology to understand how each model contributes to the composite score.
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer